Europe: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Europe

The Europe prophylactic medicaments containing insulin market dropped modestly to $X in 2022, almost unchanged from the previous year. The market value increased at an average annual rate of X% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The level of consumption peaked at $X.7B in 2014; however, from 2015 to 2022, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Europe

In value terms, prophylactic medicaments containing insulin production shrank to $X in 2022 estimated in export price. The total output value increased at an average annual rate of X% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2013 with an increase of X%. Over the period under review, production attained the peak level at $X.4B in 2014; however, from 2015 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Europe

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses exported in Europe rose slightly to X tons, increasing by X% against the year before. Total exports indicated resilient growth from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2012 indices. The most prominent rate of growth was recorded in 2013 when exports increased by X% against the previous year. Over the period under review, the exports reached the peak figure in 2022 and are expected to retain growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports fell to $X in 2022. Over the period under review, exports, however, continue to indicate a mild reduction. The growth pace was the most rapid in 2013 when exports increased by X% against the previous year. Over the period under review, the exports attained the maximum at $X in 2014; however, from 2015 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

France represented the largest exporting country with an export of around X tons, which recorded X% of total exports. Italy (X tons) took the second position in the ranking, followed by Germany (X tons). All these countries together held near X% share of total exports. The following exporters - Hungary (X tons) and Belgium (X tons) - together made up X% of total exports.

Exports from France increased at an average annual rate of X% from 2012 to 2022. At the same time, Belgium (X%), Italy (X%) and Hungary (X%) displayed positive paces of growth. Moreover, Belgium emerged as the fastest-growing exporter exported in Europe, with a CAGR of X% from 2012-2022. Germany experienced a relatively flat trend pattern. From 2012 to 2022, the share of France, Italy and Belgium increased by X, X and X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Germany ($X), France ($X) and Italy ($X) were the countries with the highest levels of exports in 2022, with a combined X% share of total exports. Hungary and Belgium lagged somewhat behind, together comprising a further X%.

Belgium, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, among the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Europe stood at $X per ton in 2022, reducing by X% against the previous year. In general, the export price recorded a abrupt decrease. The pace of growth was the most pronounced in 2014 an increase of X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2015 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Germany ($X,541 per ton), while Belgium ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Hungary (X%), while the other leaders experienced a decline in the export price figures.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Europe

In 2022, overseas purchases of medicaments containing insulin but not antibiotics in measured doses decreased by X% to X tons, falling for the second consecutive year after five years of growth. The total import volume increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth was the most pronounced in 2020 with an increase of X%. As a result, imports attained the peak of X tons. From 2021 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports reduced sharply to $X in 2022. Overall, imports saw a relatively flat trend pattern. The growth pace was the most rapid in 2020 when imports increased by X%. As a result, imports reached the peak of $X. From 2021 to 2022, the growth of imports remained at a lower figure.

Imports by Country

In 2022, France (X tons), distantly followed by Germany (X tons), Spain (X tons), Hungary (X tons), Italy (X tons) and Belgium (X tons) represented the key importers of medicaments containing insulin but not antibiotics in measured doses, together achieving X% of total imports. The following importers - the Netherlands (X tons), the UK (X tons), Greece (X tons), Romania (X tons), the Czech Republic (X tons), Slovenia (X tons) and Poland (X tons) - together made up X% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Slovenia (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin importing markets in Europe were France ($X), Germany ($X) and Belgium ($X), together accounting for X% of total imports. The Netherlands, Hungary, the UK, Italy, Romania, the Czech Republic, Spain, Poland, Greece and Slovenia lagged somewhat behind, together comprising a further X%.

Slovenia, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in Europe amounted to $X per ton, with a decrease of X% against the previous year. Over the period under review, the import price recorded a pronounced downturn. The most prominent rate of growth was recorded in 2017 when the import price increased by X%. Over the period under review, import prices reached the maximum at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was France ($X per ton), while Spain ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :